Pelvic Angiosarcoma Around Total Hip Prosthesis
Alberto Sánchez-García1, Alberto Pérez-García1, Enrique Salmerón González1
1Department of Plastic and Reconstructive Surgery, University Hospital La Fe, Valencia, Spain.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
|November 30, 2019
Summary
Primary bone angiosarcomas are rare malignancies. This case highlights the importance of considering bone angiosarcoma in patients with severe bleeding and osteolysis, especially after prosthetic procedures, for timely diagnosis and treatment.
Area of Science:
- Oncology
- Pathology
- Orthopedic Surgery
Background:
- Angiosarcomas are rare primary bone malignancies, accounting for less than 1% of cases.
- The etiology of bone angiosarcomas is often unclear, though an association with prosthetic materials has been noted.
Observation:
- A 64-year-old woman experienced severe bleeding and hip joint osteolysis following a fall, years after prosthetic total hip arthroplasty.
- Recurrent pelvic hematoma and refractory infection necessitated prosthetic hip disarticulation despite conservative management attempts.
Findings:
- Post-mortem examination revealed disseminated angiosarcoma of the pelvic bones.
- This case underscores the aggressive nature of the disease in this specific presentation.
Implications:
- Bone angiosarcoma should be included in the differential diagnosis for patients presenting with uncontrollable bleeding and osteolysis.
- Prompt diagnosis and a combined treatment approach are crucial for improving life expectancy in bone angiosarcoma patients.
